Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The global coronary artery bypass graft procedures market was valued at USD 15.43 Billion in 2025. It is poised to grow at a CAGR of 9.40% during the forecast period of 2026-2035, and reach USD 37.89 Billion by 2035. The market growth is driven by the rising global burden of coronary artery disease, growing adoption of multiarterial and minimally invasive grafting techniques, expanding use of robotic and hybrid revascularization strategies, and increasing demand for durable conduit options across aging populations.
Base Year
Historical Period
Forecast Period
Compound Annual Growth Rate
9.4%
Value in USD Billion
2026-2035
*this image is indicative*
The market reached a value of approximately USD 15.43 Billion in 2025. Steady expansion is expected over the forecast period, supported by the continued rise in ischemic heart disease prevalence and the gradual shift toward conduit-optimized, multiarterial grafting strategies. The demand for advanced surgical platforms, including robotic systems, off-pump stabilizers, and intraoperative graft flow assessment tools, is accelerating adoption. Integration with hybrid coronary revascularization pathways and the growing role of imaging-guided planning is reinforcing procedural quality. Additionally, expanding access in emerging economies and innovation in cardiovascular devices are expected to sustain long-term cardiac surgery expansion.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Breakup by Graft Type
The market is segmented by graft type into saphenous vein grafts, internal thoracic artery grafts, and other arterial conduits, including the radial artery and right gastroepiploic artery. Saphenous vein grafts are likely to lead due to their widespread use, ease of harvesting, and suitability as supplementary conduits in multi-vessel coronary artery bypass procedures, while arterial grafts such as the left internal thoracic artery (LITA) to the left anterior descending (LAD) artery continue to demonstrate superior long-term patency and survival benefits.
Market Breakup by Surgery Type
Based on surgery type, the market is segmented into single, double, triple, and quadruple CABG procedures, reflecting the number of bypassed coronary vessels. Triple CABG is likely to dominate due to the high prevalence of multi-vessel disease in surgical candidates, while quadruple bypass procedures are typically reserved for patients with extensive coronary involvement. Procedural complexity drives demand for advanced perfusion, imaging, and stabilization systems.
Market Breakup by Region
The market is segmented by region into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is expected to dominate due to advanced cardiac surgical infrastructure, high procedural volumes, and strong reimbursement frameworks, while Europe maintains steady growth supported by long-established surgical centers. Asia Pacific is expected to expand rapidly, supported by rising cardiovascular disease burden and improving access to specialist cardiac care.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
|
Analysis Type |
Factors |
Example |
|
Market Drivers |
Rising prevalence of coronary artery disease and ischemic heart conditions globally |
Growing surgical volumes for multi-vessel disease, supporting demand for advanced grafting platforms |
|
Market Restraints |
Saphenous vein graft failure rates and competition from PCI in single-vessel disease |
Late vein graft occlusion and the rise of drug-eluting stents reduce CABG referrals in lower-risk anatomy |
|
Market Opportunities |
Expansion of robotic-assisted, off-pump, and hybrid coronary revascularization procedures |
Growing adoption of minimally invasive direct CABG and tissue-engineered conduits creating new growth avenues |
This section analyzes the key factors influencing market growth, including disease burden, technology adoption, regulatory drivers, cost dynamics, and ecosystem shifts, while integrating interlinking keywords to highlight industry-wide connections.
Rising Coronary Artery Disease Burden Driving Market Growth
The increasing global burden of coronary artery disease is a major driver of market expansion, supported by aging populations and rising prevalence of diabetes, hypertension, and metabolic syndrome. CABG remains the most commonly performed major cardiac operation worldwide, with nearly 400,000 procedures performed annually in the United States alone. The continuing shift toward multi-vessel grafting in patients with complex anatomy is sustaining surgical volumes, thereby driving growth in cardiac surgery instruments during the forecast period.
Saphenous Vein Graft Failure and PCI Competition Limiting Market Penetration
Late saphenous vein graft failure due to atherosclerosis and intimal hyperplasia remains a major clinical and economic restraint, alongside competition from percutaneous coronary intervention (PCI) in single-vessel and lower-risk anatomy. The continued evolution of drug-eluting stents and physiology-guided lesion selection is shifting some patients toward catheter-based revascularization. However, advances in conduit preservation, no-touch vein harvesting, and intraoperative graft flow assessment are gradually improving CABG outcomes, supporting sustained growth across the cardiac surgery market during the forecast period.
Robotic and Hybrid Revascularization Creating Strong Opportunities
The growing adoption of robotic-assisted CABG and hybrid coronary revascularization strategies is creating significant growth opportunities, supported by improved patient recovery and shorter hospital stays. For instance, in April 2026, peer-reviewed clinical reviews highlighted how AI-guided patient selection, robotic platforms, and hybrid pathways combining CABG with PCI are tailoring revascularization to coronary anatomy and patient profile. These advances are expanding the addressable patient pool and supporting durable, less-invasive surgical robotics solutions across the CABG market.
Minimally Invasive CABG Techniques Shaping Emerging Market Advancement
The rapid evolution of minimally invasive and catheter-based coronary artery bypass graft procedures is emerging as a key trend in the market, driven by the need to reduce surgical trauma and improve patient outcomes. For instance, in January 2026, a research team from the National Heart, Lung, and Blood Institute (NIH) and Emory School of Medicine, alongside cardiologists, performed the first coronary artery bypass procedure without opening the chest. They used a catheter-based technique via the leg artery to conclude this procedure. This advancement significantly shortens recovery time and minimizes procedural risks compared to traditional open-heart surgery. Such innovations are reshaping surgical approaches, accelerating the shift toward less invasive revascularization strategies, and redefining clinical workflows across the CABG landscape.
Saphenous Vein Grafts Likely to Dominate the Market Segment by Graft Type
Saphenous vein grafts are likely to dominate the market, accounting for about 45% share in the historical period, driven by their widespread use, ease of harvesting, and suitability for multi-vessel CABG procedures. Their role in improving cardiac surgery outcomes and procedural flexibility supports consistent demand. In contrast, arterial grafts such as the left internal thoracic artery (LITA) to the left anterior descending (LAD) artery demonstrate superior long-term patency and survival outcomes, while advancements in minimally invasive surgery and off-pump techniques enhance overall efficiency.
North America is likely to dominate the market as it accounted for about 38% share in the historical period, supported by advanced cardiac surgical infrastructure, high procedural volumes, and strong reimbursement frameworks. The region benefits from early adoption of robotic platforms and hybrid revascularization pathways, strengthening healthcare technology integration. Additionally, the presence of specialized cardiac centers and structured rehabilitation programs supports better cardiovascular treatment outcomes and sustained market growth during the forecast period.
Boston Scientific Corporation, headquartered in Marlborough, Massachusetts, United States, was established in 1979 and is a global leader in medical devices for cardiovascular, rhythm, and neuromodulation applications. Its portfolio supports cardiac surgery and structural heart procedures, contributing to the broader cardiovascular intervention segment through advanced delivery and imaging technologies.
Ethicon US, LLC., headquartered in Raritan, New Jersey, United States, is a Johnson & Johnson MedTech company founded in 1949 and is a leading provider of surgical sutures, energy devices, and wound closure products. Its portfolio is widely used across cardiac surgery for graft anastomosis and haemostasis, reinforcing its position in the surgical instruments and consumables segment.
MAQUET Holding B.V. & Co. KG, headquartered in Rastatt, Germany, is part of the Getinge Group and operates across cardiopulmonary, surgical workflow, and intensive care segments. Its portfolio includes the VasoView endoscopic vessel harvesting system and off-pump stabilisers widely used in CABG, holding a strong position in the cardiac surgery instrumentation segment.
Genesee Biomedical Inc., headquartered in Denver, Colorado, United States, was founded in 1991 and specializes in cardiac surgery instruments and retraction systems. Its portfolio includes a comprehensive range of internal thoracic artery retractors and CABG instrument sets used in open and minimally invasive bypass procedures, supporting its niche position within the cardiac surgical accessories segment.
Other key players in the market include KARL STORZ GmbH & Co. KG and many more.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Graft Type |
|
| Breakup by Surgery Type |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share